Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Victoria Werth MD

Victoria P. Werth MD

Professor of Dermatology, Department of Dermatology, University of Pennsylvania; Chief, Dermatology, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania

Dr. Victoria Werth is a Professor of Dermatology and Medicine, University of Pennsylvania School of Medicine and Chief of Dermatology, Philadelphia VAMC.  She is an internist and dermatologist with a practice devoted to autoimmune skin diseases.  She has guided development and validation of disease severity tools currently being used in lupus, dermatomyositis, and autoimmune blistering disease studies.  She is leading a multicenter collaborative, web-based database to collect prospective information on patients with skin and systemic manifestations of lupus erythematosus. This is the first systematic epidemiologic study of cutaneous lupus erythematosus in the United States. With the information collected on now over 350 patients at the University of Pennsylvania alone, we have performed the first prospective evaluations of cutaneous lupus erythematosus in order to assess disease severity, quality of life, and response to treatment, as well as complete validation studies of the CLASI, a disease severity tool for cutaneous lupus.  Her investigational laboratory studies relate to biomarkers in cutaneous lupus and ultraviolet light effects on skin. Recent studies have examined mechanistic effects of therapeutics in CLE, as well as subset-specific expression of interferon signatures.  Dr. Werth is a member of the Medical & Scientific Committee of the Lupus Foundation of America, Associate Editor for the Lupus Science & Medicine journal, and her research has been funded by the Alliance for Lupus Research, Lupus Foundation of America, Lupus Research Institute, NIH, and the VA.